AN ACT CONCERNING HEALTH INSURANCE COVERAGE FOR INSULIN.

HB 5279 prohibits health insurance companies from classifying insulin as a "preferred" or "required" drug for people diagnosed with insulin-dependent or insulin-using diabetes. It also bans insurers from requiring doctors to seek prior approval, review, or appeal before prescribing insulin to these patients. The bill directly affects diabetic patients who rely on insulin and their healthcare providers by removing these insurer barriers. This policy change ensures doctors can prescribe needed insulin without insurance delays or restrictions.